GRFS (GRFS) Stock Price & Analysis
GRFS (GRFS) rose 0.14% to USD 7.34 as of June 9, 2026 at 23:52 UTC, according to Nexqual real-time market data.
GRFS last closed at USD 7.33; the session ranged USD 7.32–7.53 on volume of 733,810 shares. Market capitalization is $5.00B, with a 52-week range of USD 7.32–11.14 (NMS). Source: Nexqual, June 9, 2026 at 23:52 UTC.
Key Statistics (as of June 9, 2026 at 23:52 UTC)
| Price | USD 7.34 |
|---|---|
| Change | ▲ 0.14% (up) |
| Previous Close | USD 7.33 |
| Open | USD 7.49 |
| Day Range | USD 7.32 – 7.53 |
| 52-Week Range | USD 7.32 – 11.14 |
| Volume | 733,810 shares |
| Market Cap | $5.00B |
| Exchange | NMS |
Technical Analysis (GRFS)
Nexqual's technical model rates GRFS "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 9, 2026 at 23:52 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 34.35 (neutral) |
| vs SMA50 | Below (USD 8.04) |
| MACD | -0.17 (negative) |
Analyst Ratings (GRFS)
Wall Street analysts rate GRFS "None" based on 2 analysts, with a mean price target of USD 10.87 (range USD 10–11.73), per Nexqual as of June 9, 2026 at 23:52 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 10.87 |
| High Target | USD 11.73 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 1 / 1 / 0 |
Earnings (GRFS)
| EPS Estimate | USD 0.28 |
|---|---|
| Revenue Estimate | $1.95B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-06-30 | USD 0.22 vs est 0.28 ▼ miss |
Source: Nexqual, June 9, 2026 at 23:52 UTC.
Financials & Fundamentals (GRFS)
| Total Revenue | $7.44B |
|---|---|
| Revenue Growth (YoY) | -4.80% |
| Gross Margin | +38.36% |
| Operating Margin | +16.47% |
| Profit Margin | +5.58% |
| ROE | +6.13% |
| Debt / Equity | 123.22 |
| Current Ratio | 2.47 |
| Total Cash | $702.00M |
| Total Debt | $9.67B |
| Free Cash Flow | $887.54M |
Source: Nexqual, June 9, 2026 at 23:52 UTC.
Financial Health Score (GRFS)
Nexqual rates GRFS's overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 23:52 UTC.
| Growth | Mixed — Revenue +4.3% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 38%, operating 16% |
| Balance Sheet | Mixed — $702M cash vs $9.67B debt |
| Cash Flow | Solid — FCF $888M, 12% margin |
| Efficiency | Mixed — ROE 6%, ROA 4.2% |
Ownership (GRFS)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +58.19% |
| Shares Outstanding | 680.58M |
| Float | 834.63M |
Source: Nexqual, June 9, 2026 at 23:52 UTC.
Leadership (GRFS)
GRFS is led by Jose Ignacio Abia Buenache (age 57), CEO & Director, per Nexqual as of June 9, 2026 at 23:52 UTC.
| CEO & Director | Jose Ignacio Abia Buenache (age 57) |
|---|---|
| Chief Financial Officer | Rahul Srinivasan (age 48) |
| Senior Vice President of Strategy & COO Office | Lluis Pons Gomez (age 41) |
| Head of Investor Relations & Sustainability and Vice President | Daniel Segarra |
| President of Commercial Tech Support | Sergio Roura Adell (age 56) |
Major Backers & Investors (GRFS)
Notable institutional backers of GRFS include Brandes Investment Partners L.P., Capital Group, Permian Investment Partners, Lp, according to Nexqual as of June 9, 2026 at 23:52 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Brandes Investment Partners L.P. | 13.9% |
| Capital Group | 8.77% |
| Permian Investment Partners, Lp | 7.4% |
| NEW PERSPECTIVE FUND | 5.37% |
| Black Creek Investment Management Inc. | 3.21% |
| Datum One Series Trust-BRANDES INTERNATIONAL SMALL CAP EQUITY FUND | 2.29% |
| Intl Growth & Income Fd.-Intl Growth and Income Fd. | 1.98% |
| Millennium Management | 1.91% |
Source: Nexqual, June 9, 2026 at 23:52 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HCM | HUTCHMED (China) Limited | USD 10.63 | ▼ 2.21% |
| LIVN | LivaNova PLC | USD 77.17 | ▲ 6.65% |
| IRWD | Ironwood Pharmaceuticals, Inc. | USD 3.22 | ▼ 2.72% |
| FMS | Fresenius Medical Care AG | USD 22.35 | ▲ 1.45% |
| LKFT | Lakefront Biotherapeutics | USD 28.27 | ▲ 0.89% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:52 UTC. This page is informational and not investment advice.